| Fiscal period | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|
| Period End Date | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 |
|---|
| Sales | 6,004.80 | 5,382.40 | 5,232.50 | 4,386.30 | 4,348.00 | 3,722.80 | 3,435.30 | 2,963.70 | 2,493.70 | 2,322.90 |
| Total Revenues | 6,004.80 | 5,382.40 | 5,232.50 | 4,386.30 | 4,348.00 | 3,722.80 | 3,435.30 | 2,963.70 | 2,493.70 | 2,322.90 |
| Cost of goods sold | 1,379.80 | 1,080.40 | 1,248.90 | 1,080.60 | 1,114.40 | 939.40 | 875.30 | 797.40 | 617.20 | 625.60 |
| Gross Profit | 4,625.00 | 4,302.00 | 3,983.60 | 3,305.70 | 3,233.60 | 2,783.40 | 2,560.00 | 2,166.30 | 1,876.50 | 1,697.30 |
| Goodwill amortization | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Research and development expenses | 1,071.80 | 945.20 | 903.10 | 760.70 | 752.70 | 622.20 | 552.60 | 443.30 | 383.10 | 346.50 |
| Purchased in-process research and development expenses | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Selling, general and administrative expenses | 1,824.60 | 1,567.60 | 1,493.70 | 1,228.40 | 1,242.20 | 1,088.50 | 984.70 | 904.70 | 850.70 | 858.00 |
| Non-recurring spin-off expenses | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Other operating income | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Special charges | (17.20) | (60.70) | -- | -- | (64.60) | (116.20) | -- | -- | -- | -- |
| Change in fair value of contingent consideration liabilities | 26.20 | 35.80 | 124.10 | (13.60) | 6.10 | 5.70 | 9.90 | -- | -- | -- |
| Intellectual property litigation expenses (income), net | (203.50) | (15.80) | (20.60) | (405.40) | (33.40) | -- | -- | -- | -- | -- |
| Operating (loss) income | 1,534.10 | 1,748.50 | 1,690.30 | 897.60 | 1,146.80 | -- | -- | -- | -- | -- |
| Interest expense, net | 17.60 | 19.20 | 18.40 | 15.80 | 20.70 | 29.90 | 23.20 | 19.20 | 17.20 | 17.20 |
| Special (gains) charges, net | -- | -- | -- | -- | -- | (7.10) | 59.90 | 34.50 | -- | 70.70 |
| Asset impairments | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Intellectual property litigation expense (income), net | -- | -- | -- | -- | -- | 214.00 | (73.30) | 32.60 | 7.00 | (740.40) |
| Disposition of assets and other non-recurring charges, net | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Interest income | 67.20 | 35.50 | 17.40 | 23.40 | 32.20 | 32.00 | 20.30 | 10.80 | 7.90 | 6.40 |
| Other (expense) income, net | 14.40 | 2.60 | 12.70 | 11.50 | 8.20 | 4.00 | (8.20) | (4.90) | (4.00) | (7.70) |
| Pre-Tax Income: United States | -- | -- | -- | 151.30 | -- | -- | 491.50 | 378.20 | 182.80 | 791.10 |
| Income before provision for income taxes | 1,598.10 | 1,767.40 | 1,702.00 | 916.70 | 1,166.50 | 761.40 | 1,034.90 | 737.90 | 622.40 | 1,144.00 |
| International, including Puerto Rico | -- | -- | -- | 765.40 | -- | -- | 543.40 | 359.70 | 439.60 | 352.90 |
| Provision for income taxes | 198.70 | 245.50 | 198.90 | 93.30 | 119.60 | 39.20 | 451.30 | 168.40 | 127.50 | 332.90 |
| Current - United States: Federal | 317.30 | 369.10 | 125.20 | 23.40 | 31.30 | 10.90 | 330.80 | 153.40 | 102.40 | 341.50 |
| Current - United States: State and local | 58.10 | 60.60 | 25.10 | 48.20 | 48.70 | 13.60 | 32.80 | 12.10 | 7.40 | 23.30 |
| Current - International, including Puerto Rico | 85.30 | 66.70 | 92.60 | 73.90 | 29.10 | 35.90 | 60.60 | 27.40 | 33.50 | 34.80 |
| Deferred - United States: Federal | (187.50) | (187.70) | (9.40) | 11.00 | 28.30 | (16.10) | 39.30 | (19.60) | (12.50) | (46.40) |
| Deferred - United States: State and local | (54.20) | (58.90) | (25.40) | (32.90) | (18.30) | (22.40) | (3.80) | (4.30) | (2.60) | (8.10) |
| Deferred - International, including Puerto Rico | (20.30) | (4.30) | (9.20) | (30.30) | 0.50 | 17.30 | (8.40) | (0.60) | (0.70) | (12.20) |
| Income Before Extraordinary Income & Accounting Change | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Cumulative Effect of Change in Accounting Principle | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Income (loss) | 1,399.40 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net loss attributable to noncontrolling interest | (3.00) | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net income (loss) attributable to common stockholders | 1,402.40 | 1,521.90 | 1,503.10 | 823.40 | 1,046.90 | 722.20 | 583.60 | 569.50 | 494.90 | 811.10 |
| Income before cumulative effect of change in accounting principle - Basic | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Cumulative effect of change in accounting principle - basic | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Earnings (loss) per share: Basic | 2.31 | 2.46 | 2.41 | 1.32 | 1.68 | 1.15 | 0.92 | 0.89 | 0.77 | 1.27 |
| Income before cumulative effect of change in accounting principle - Diluted | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Cumulative effect of change in accounting principle - diluted | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Earnings (loss) per share: Diluted | 2.30 | 2.44 | 2.38 | 1.30 | 1.64 | 1.13 | 0.90 | 0.87 | 0.75 | 1.25 |
| Weighted average number of common shares outstanding: Basic | 606.70 | 619.00 | 623.30 | 622.60 | 624.90 | 627.60 | 632.70 | 639.00 | 646.50 | 639.00 |
| Weighted average number of common shares outstanding: Diluted | 609.40 | 624.20 | 631.20 | 631.90 | 636.60 | 640.80 | 647.70 | 653.40 | 660.90 | 651.00 |